Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Largest US Registry Study Supports Two-Year Safety, Reduced Revascularizations, for DES
Link ID 351
Title Largest US Registry Study Supports Two-Year Safety, Reduced Revascularizations, for DES
Url http://www.medscape.com/viewarticle/565348?src=rss
Description At two years, DES were associated with comparable MI rates but statistically significant reductions in mortality and revascularizations. Investigators say they will continue to track the 17 000+ patients for at least five years, but for now the findings are "reassuring." Heartwire
Category Articles > Cardiology
Keywords
Date Nov 6, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Wrong ACS Patients Are Being Referred for Angiography
  Cardiac catheterization is not being used optimally in patients with non-ST-elevation acute coronary syndrome because clinicians are not risk-stratifying these patients correctly. Medscape Medical News
Category:   Articles > Cardiology


2. IDEAL: Lowering Triglycerides in Stable Statin-Treated CHD Patients Does Not Provide Benefit
  This most recent analysis showed that while elevated plasma triglycerides identified patients at increased risk for recurrence of disease, the association depended on other risk factors, especially HDL cholesterol. Heartwire
Category:   Articles > Cardiology


3. World Needs to ENDORSE Better VTE Prevention
  A large international trial shows that prophylaxis for venous thromboembolism in the acute hospital care setting is substantially underused worldwide. One of the main reasons for this is the reluctance of some doctors to recognize the benefits of VTE prevention--either because of their specialty or because of where they live, say the researchers. Heartwire
Category:   Articles > Cardiology


4. ADAGIO-LIPIDS: Rimonabant Reduces Visceral Fat and Improves Lipid Parameters
  A new rimonabant study presented this week showed that the drug improved lipid parameters, but more important, reduced visceral adipose tissue, the type of abdominal obesity that contributes to big waistlines and type 2 diabetes. Heartwire
Category:   Articles > Cardiology


5. What Your Patients Are Reading: Smoking, Diet, Exercise May Influence Breast Cancer Survival
  Modifiable risk factors may influence breast cancer survival; statins modesty but significantly lower blood pressure; postmenopausal hormones may reduce risk for neovascular but not early age-related macular degeneration; postpartum depression affects younger, less well-educated women more than others; and mumps cases related to possible vaccine failures are on the rise. Medscape Medical News
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS